1Daly C A, Hildebrandt P, Bertrand M, et al. Adverse prognosis asso- ciated with themetabolic syndrome in established coronary artery dis- ease, data from the EUROPA trial[ J ]. Heart,2007,93 ( 11 ) : 1406 - 1411. 被引量：1
2Varpula M, Pulkki K, Karlsson S, et al. Predictive value of Ntermi- nal pro - brain rmtrluretle peptide in severe sepsis and septic shock [ J ]. Crit Care Med,2007,35 ( 5 ) : 1277 - 1283. 被引量：1
3Krishnankutty S. Lipoprotein -associated phospholipase A2, vascular inflammation and cardiovascular risk prediction [ J ]. Vascular Health and Risk Management,2006,2 ( 2 ) : 153 - 156. 被引量：1
4Puddu P, Puddu GM, Cravero E, et al. The molecular sources of re- active oxygen species in hypertension[J]. Blood Press,2008,17 (2) : 70 -77. 被引量：1
5Lavi S, McConnell JP,Rihal CS,et al. Local production of lipoprotein -associated phospholipase A2 and lyso -phosphatidylcholine in the coronary circulation:association with early coronary atherosclerosis and endothelial dysfunction in humans [J]. Circulation ,2007,115:2715 - 2721. 被引量：1
